Nu-Med Plus (NUMD) Net Income towards Common Stockholders (QoQ) (2013 - 2025)
Nu-Med Plus (NUMD) Net Income towards Common Stockholders (QoQ) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.10 Bn | 7.27 Bn |
| 2 | Stryker | 127.86 Bn | 124.38 Bn | 4.50 Bn |
| 3 | Medtronic | 119.05 Bn | 109.83 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.61 Bn | 73.07 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.00 Bn | 47.75 Bn | 1.35 Bn |
| 6 | Dexcom | 34.36 Bn | 32.42 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.85 Bn | 31.74 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.38 Bn | 23.06 Bn | 4.55 Bn |
| 9 | Steris | 23.08 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.45% |
| Sep 30, 2025 | -2.58% |
| Jun 30, 2025 | 41.48% |
| Mar 31, 2025 | -88.85% |
| Dec 31, 2024 | 43.49% |
| Sep 30, 2024 | -8.04% |
| Jun 30, 2024 | 20.80% |
| Mar 31, 2024 | 61.44% |
| Dec 31, 2023 | -244.97% |
| Sep 30, 2023 | 32.54% |
| Jun 30, 2023 | 13.77% |
| Mar 31, 2023 | -166.20% |
| Dec 31, 2022 | 173.40% |
| Sep 30, 2022 | 0.03% |
| Jun 30, 2022 | 2.65% |
| Mar 31, 2022 | 97.27% |
| Dec 31, 2021 | -1,746.29% |
| Sep 30, 2021 | 51.21% |
| Jun 30, 2021 | 32.00% |
| Mar 31, 2021 | 29.73% |